Latest news
Hopstem Closes First Series C Financing to Advance iPSC Neural Cell Therapy - citybizcitybiz · Mon, 10 Aug 2026 12:56:43 GMTHopstem Announces the first Closing of Series C Financing to Accelerate the Development of iPSC-Derived Forebrain Neural Cell Therapy - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 10:17:42 GMT